J. T. Burke

444 total citations
15 papers, 379 citations indexed

About

J. T. Burke is a scholar working on Transplantation, Psychiatry and Mental health and Surgery. According to data from OpenAlex, J. T. Burke has authored 15 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Transplantation, 5 papers in Psychiatry and Mental health and 3 papers in Surgery. Recurrent topics in J. T. Burke's work include Renal Transplantation Outcomes and Treatments (7 papers), Neurological Complications and Syndromes (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). J. T. Burke is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Neurological Complications and Syndromes (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). J. T. Burke collaborates with scholars based in France, United States and Spain. J. T. Burke's co-authors include Jean‐Paul Thénot, Jan Koch‐Weser, P Guillet, Alain Reinberg, Martin Blum, William A. Wargin, Josep M. Campistol, J.-P Squifflet, C. Legendre and Thomas Buckley and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Transplantation and British Journal of Clinical Pharmacology.

In The Last Decade

J. T. Burke

15 papers receiving 347 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. T. Burke 77 67 63 61 48 15 379
Toshiaki Nagano 78 1.0× 31 0.5× 24 0.4× 7 0.1× 7 0.1× 24 426
Toru Mochizuki 111 1.4× 7 0.1× 47 0.7× 11 0.2× 5 0.1× 31 541
E. Schröder 120 1.6× 13 0.2× 64 1.0× 2 0.0× 11 0.2× 42 553
Martine Grosber 111 1.4× 264 3.9× 57 0.9× 1 0.0× 16 0.3× 41 725
Kyriaki Aroni 20 0.3× 16 0.2× 51 0.8× 1 0.0× 9 0.2× 27 426
Hsiu‐Ying Yu 23 0.3× 2 0.0× 28 0.4× 6 0.1× 133 2.8× 37 481
John Schwarz 87 1.1× 101 1.5× 35 0.6× 23 0.5× 16 400
Armin Buchwald 120 1.6× 1 0.0× 42 0.7× 32 0.5× 14 0.3× 10 322
Philip I Hair 58 0.8× 25 0.4× 56 0.9× 9 0.2× 12 385
D. Sampson 52 0.7× 18 0.3× 22 0.3× 67 1.4× 16 424

Countries citing papers authored by J. T. Burke

Since Specialization
Citations

This map shows the geographic impact of J. T. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. T. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. T. Burke more than expected).

Fields of papers citing papers by J. T. Burke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. T. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. T. Burke. The network helps show where J. T. Burke may publish in the future.

Co-authorship network of co-authors of J. T. Burke

This figure shows the co-authorship network connecting the top 25 collaborators of J. T. Burke. A scholar is included among the top collaborators of J. T. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. T. Burke. J. T. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Morales, J.M., Anders Hartmann, Rowan G. Walker, et al.. (2009). Similar Lipid Profile But Improved Long-Term Outcomes With Sirolimus After Cyclosporine Withdrawal Compared to Sirolimus With Continuous Cyclosporine. Transplantation Proceedings. 41(6). 2339–2344. 2 indexed citations
2.
Morales, J.M., Josep M. Campistol, Henri Kreis, et al.. (2005). Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients. Transplantation Proceedings. 37(2). 693–696. 29 indexed citations
4.
Legendre, C., Josep M. Campistol, J.-P Squifflet, & J. T. Burke. (2003). Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation. Transplantation Proceedings. 35(3). S151–S153. 31 indexed citations
5.
Bäckman, Lars, Henri Kreis, Jorge Morales, et al.. (2002). Sirolimus steady‐state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients. British Journal of Clinical Pharmacology. 54(1). 65–68. 16 indexed citations
6.
Claesson, Kerstin, C Brattström, & J. T. Burke. (2001). Sirolimus and erythromycin interaction: two cases. Transplantation Proceedings. 33(3). 2136–2136. 8 indexed citations
7.
Burke, J. T.. (2000). Contract as commodity: a non-fiction statutory approach. Statute Law Review. 21(1). 12–42. 1 indexed citations
8.
Collins, Anna, Éric Palmer, J. Bézard, et al.. (1997). A comparison of the biochemical composition of equine follicular fluid and serum at four different stages of the follicular cycle. Equine Veterinary Journal. 29(S25). 12–16. 36 indexed citations
9.
Johnston, A. E., et al.. (1997). 62 VALIDATION OF A HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR SIROLIMUS. Therapeutic Drug Monitoring. 19(5). 562–562. 1 indexed citations
10.
Burke, J. T. & Jean‐Paul Thénot. (1985). Determination of antiepileptic drugs. Journal of Chromatography B Biomedical Sciences and Applications. 340. 199–241. 46 indexed citations
11.
Burke, J. T., et al.. (1982). Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function. Journal of Pharmacokinetics and Biopharmaceutics. 10(6). 601–614. 28 indexed citations
12.
Burke, J. T., William A. Wargin, & Martin Blum. (1980). High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinate. Journal of Pharmaceutical Sciences. 69(8). 909–912. 18 indexed citations
13.
Brent, David A., et al.. (1980). Rearrangement of chloramphenicol-3-monosuccinate. Journal of Pharmaceutical Sciences. 69(8). 906–908. 17 indexed citations
14.
Reinberg, Alain, et al.. (1978). Chronopharmacological study of antihistamines in man with special references to terfenadine. European Journal of Clinical Pharmacology. 14(4). 245–252. 61 indexed citations
15.
Burke, J. T., et al.. (1977). Inhibitory activity of terfenadine on histamine-induced skin wheals in man. European Journal of Clinical Pharmacology. 12(3). 195–199. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026